Unlocking Value in Aging Markets
As the global population ages, a seismic shift is reshaping industries, from healthcare to finance. By 2030, one…
I Launched a Healthcare Startup With Nearly $1M ARR With No Experience
Zak Marks, 27, is the cofounder and CEO of Kitt Medical, a company that supplies wall-mounted emergency kits…
WHO and Noora Health begin collaboration to strengthen support for family caregivers
The World Health Organization (WHO) and Noora Health have signed a three-year Memorandum of Understanding (MoU) to enhance…
Invest in Courageous, Progressive Journalism
The struggle for democracy persists as we come into the second half of 2023. As the year progresses,…
GSK profits lifted by strong cancer drug sales
Strong sales of specialty medicines during the first half of the year have led GSK to expect group…
America’s ailing health insurers
Few firms in America are more unloved than health insurers. As gatekeepers of the world’s costliest health-care system,…
NHS failed to hear concerns of family in death of five-year-old boy
Grace Wood BBC News, Yorkshire Handout Yusuf Nazir died eight days after he was sent home from hospital…
Smartphone-based Parkinson’s and dementia platform launches in US
FDA clears tremor monitoring module as Neu Health launches phone-based tech that detects subtle indicators of neurological decline.…
You can’t test your way to health
More tests, more scans, more treatments—we’re told this is the road to health. It’s not. In our obsession…
Medicaid let me bring my dying daughter home. The “Big, Beautiful, Bill” might change that.
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to…
The Future Of Chronic Condition Management: Living Better For Longer
We’re entering a new era of chronic condition care, where the latest weight-loss medications will allow employers to…
UnitedHealth Provides Painful 2025 Prognosis Amid Spiraling Treatment Costs
The world’s largest healthcare insurer issued a self-diagnosis Tuesday: UnitedHealth’s second-quarter results call for lots of paracetamol, as…